Denounce with righteous indignation and dislike men who are beguiled and demoralized by the charms pleasure moment so blinded desire that they cannot foresee the pain and trouble.
Read More
GENERAL BACKGROUND
In July 2015, the International Agency for Research on Cancer (IARC), a specialized intergovernmental agency of the World Health Organization (WHO), issued a final health assessment of glyphosate the active chemical in Monsanto Company’s Roundup® herbicide determining that glyphosate is a Group 2A agent, “probably carcinogenic to humans.” IARC specifically linked exposure to Roundup® to non-Hodgkin lymphoma (NHL), (including its various subtypes such as lymphocytic lymphoma / chronic lymphocytic leukemia, B-cell lymphoma, hairy cell leukemia, and others.
QUALIFYING INJURIES
- Non-Hodgkin’s Lymphoma
- B or T-Cell Lymphoma
- Chronic Lymphocytic Leukemia
- Hairy Cell Lymphoma
- Mantle Cell Lymphoma
CRITERIA
- PC must have been diagnosed with Non- Hodgkin’s Lymphoma, B or T-Cell Lymphoma, Chronic Lymphocyte Leukemia, Hairy Cell Lymphoma, or Mantle Cell Lymphoma
- PC must have been exposed to Roundup up in 1990 or later
- PC must have used product for at least 1 year
- PC must have been diagnosed at least 3 years after first use of Roundup
- PC must be diagnosed in 2000 or later
- PC must have been 14-75 at time of diagnosis
- PC must be 75 or younger at sign up
- PC must not have any of the following prior to NHL diagnosis:
- HIV or AIDS diagnosis, Hep B or C diagnosis, Agent Orange exposure, Organ transplant recipient, Prior chemotherapy (prior to use of products)
- PC must not currently be represented by an attorney
- If deceased, death must be within 10 years